New treatments for breast cancer: Breakthroughs for patient care or just steps in the right direction?adjuvant paclitaxelbreast cancerHerceptin™preventionRaloxifeneTamoxifenThree areas of clinical research in breast cancer treatment led to news breaking presentations at the American Society of Clinical ...
who chairs the radiation oncology department at Johns Hopkins, who was not involved in the clinical trial. "It is much easier for patients to come in for just five treatments than to come in every single day for six weeks. It's a very positive approach, from the patient's perspective, f...
The newest targeted therapies are helping doctors to tailor increasingly effective treatments to individual patients
Triple-negativebreast cancer, or TNBC, affects 10–15% of patients with breast cancer in the US. TNBC is called "triple-negative" because the cancer lacks anestrogen receptor, aprogesterone receptor, and a HER2 (human epidermal growth factor) receptor. The absence of any of these receptors—r...
Smith G, Henderson C: New treatments for breast cancer. Semin Oncol 23:506-528, 1996Smith G, Henderson IC: New treatments for breast cancer. Semin Oncol 23(4): 506 28, 1996.Smith G,Henderson IC. New treatments for breast cancer.[J].Seminars in Oncology 1996,4(4)....
New Drugs Putting the Brakes on Cancer Cells Researchers now know that breast cancer is actually a number of different diseases. That discovery has led to the development of several new treatments that target specific types of tumors in the breast. ...
In an interview with Pharmacy Times, Danielle Roman, PharmD, BCOP, oncology clinical pharmacy specialist at Allegheny Health Network, discussed updates in treatments for breast cancer, including HER2–low, HR–positive, HER2, and triple negative breast cancers. Both immunotherapies and targeted therapie...
University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments for triple-negative breast cancer. Triple-negative breast cancer, which accounts for about 10%–15% of all breast cancers, is an aggressive type of cancer that has limited tr...
Great advances have been made in treatment for breast cancer that have led to great survival rates for women with stage I through III breast cancer, but those same women often experience late effects or side effects from their treatments. Those include things like fatigue, exercise intolerance, ...
While several inflammatory cell types participate in cancer development, macrophages specifically play a key role in breast cancer, where they appear to be... A Press 被引量: 0发表: 0年 New treatments for breast cancer. The development of new treatments for breast has been fueled by the plate...